Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 33.80
+2.21 (7.00%)
At close: Oct 23, 2026
SHA:688139 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,519 | 2,316 | 2,274 | 2,272 | 2,855 | 2,119 |
Other Revenue | 12.2 | 12.2 | 9.85 | 9.24 | 8.62 | 7.31 |
| 2,531 | 2,329 | 2,284 | 2,281 | 2,864 | 2,126 | |
Revenue Growth | 11.86% | 1.96% | 0.13% | -20.36% | 34.72% | 51.63% |
Cost of Revenue | 1,342 | 1,247 | 1,190 | 1,174 | 1,490 | 1,061 |
Gross Profit | 1,189 | 1,082 | 1,094 | 1,107 | 1,374 | 1,065 |
Selling, General & Admin | 602.16 | 552.22 | 471.73 | 476.68 | 513.72 | 388.03 |
Research & Development | 345.93 | 323.25 | 306.17 | 320.64 | 292.47 | 236.31 |
Other Operating Expenses | 1.9 | -2.74 | -6.48 | -7.25 | 2.34 | 1.63 |
Operating Expenses | 950.96 | 885.88 | 787.08 | 793.97 | 809.08 | 622.71 |
Operating Income | 238.15 | 195.77 | 306.58 | 312.95 | 564.67 | 441.98 |
Interest Expense | -3.87 | -3.91 | -3.41 | -3.51 | -2.69 | -2.89 |
Interest & Investment Income | 60.05 | 62.68 | 71.46 | 118.64 | 95.02 | 483.95 |
Currency Exchange Gain (Loss) | -2.38 | -2.38 | 4.46 | -7.72 | 3.58 | 4.14 |
Other Non Operating Income (Expenses) | -16.65 | -3.44 | -1.87 | -1.64 | -1.49 | 0.56 |
EBT Excluding Unusual Items | 275.3 | 248.72 | 377.21 | 418.71 | 659.1 | 927.74 |
Gain (Loss) on Sale of Investments | -0.93 | -0.49 | 5.47 | 2.06 | -7.01 | 10.21 |
Gain (Loss) on Sale of Assets | 0.32 | 0.63 | 0.23 | -1.6 | -0.76 | -0.52 |
Asset Writedown | -1.71 | -1.23 | -1.86 | -2.36 | - | - |
Other Unusual Items | 19.24 | 17.13 | 20.9 | 17.69 | 24 | 23.44 |
Pretax Income | 292.22 | 264.76 | 401.96 | 434.49 | 675.34 | 960.87 |
Income Tax Expense | 13.1 | 9.63 | 20.95 | 22.43 | 63.36 | 111.7 |
Earnings From Continuing Operations | 279.12 | 255.13 | 381.01 | 412.06 | 611.97 | 849.17 |
Minority Interest in Earnings | -7.07 | -4.4 | -14.38 | -5.99 | -11.18 | -4.14 |
Net Income | 272.05 | 250.73 | 366.63 | 406.07 | 600.79 | 845.04 |
Net Income to Common | 272.05 | 250.73 | 366.63 | 406.07 | 600.79 | 845.04 |
Net Income Growth | 6.32% | -31.61% | -9.71% | -32.41% | -28.90% | 121.82% |
Shares Outstanding (Basic) | 313 | 313 | 316 | 317 | 318 | 316 |
Shares Outstanding (Diluted) | 313 | 313 | 316 | 317 | 318 | 318 |
Shares Change | -0.96% | -0.84% | -0.37% | -0.20% | 0.06% | -2.43% |
EPS (Basic) | 0.87 | 0.80 | 1.16 | 1.28 | 1.89 | 2.67 |
EPS (Diluted) | 0.87 | 0.80 | 1.16 | 1.28 | 1.89 | 2.66 |
EPS Growth | 7.34% | -31.03% | -9.38% | -32.27% | -28.95% | 127.35% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 281.33 | 148.64 | 164.96 | 72.08 | 338.18 | 387.11 |
Free Cash Flow Per Share | 0.90 | 0.47 | 0.52 | 0.23 | 1.06 | 1.22 |
Dividend Per Share | 0.330 | 0.330 | 0.470 | 0.515 | 0.450 | 0.500 |
Dividend Growth | -29.79% | -29.79% | -8.74% | 14.44% | -10.02% | 31.61% |
Gross Margin | 46.97% | 46.45% | 47.89% | 48.53% | 47.97% | 50.08% |
Operating Margin | 9.41% | 8.41% | 13.42% | 13.72% | 19.72% | 20.79% |
Profit Margin | 10.75% | 10.77% | 16.05% | 17.80% | 20.98% | 39.75% |
Free Cash Flow Margin | 11.11% | 6.38% | 7.22% | 3.16% | 11.81% | 18.21% |
EBITDA | 340.01 | 303.74 | 422.71 | 410.67 | 626.73 | 491.15 |
EBITDA Margin | 13.43% | 13.04% | 18.51% | 18.00% | 21.88% | 23.10% |
D&A For EBITDA | 101.86 | 107.97 | 116.13 | 97.72 | 62.06 | 49.17 |
EBIT | 238.15 | 195.77 | 306.58 | 312.95 | 564.67 | 441.98 |
EBIT Margin | 9.41% | 8.41% | 13.42% | 13.72% | 19.72% | 20.79% |
Effective Tax Rate | 4.48% | 3.64% | 5.21% | 5.16% | 9.38% | 11.63% |
Revenue as Reported | 2,531 | 2,329 | 2,284 | 2,281 | 2,864 | 2,126 |
Advertising Expenses | - | 35.16 | 24.88 | 31.82 | 25.41 | 14.24 |